Identification of phenylisoxazolines as novel and viable antibacterial agents active against gram-positive pathogens

被引:82
作者
Barbachyn, MR [1 ]
Cleek, GJ [1 ]
Dolak, LA [1 ]
Garmon, SA [1 ]
Morris, J [1 ]
Seest, EP [1 ]
Thomas, RC [1 ]
Toops, DS [1 ]
Watt, W [1 ]
Wishka, DG [1 ]
Ford, CW [1 ]
Zurenko, GE [1 ]
Hamel, JC [1 ]
Schaadt, RD [1 ]
Stapert, D [1 ]
Yagi, BH [1 ]
Adams, WJ [1 ]
Friis, JM [1 ]
Slatter, JG [1 ]
Sams, JP [1 ]
Oien, NL [1 ]
Zaya, MJ [1 ]
Wienkers, LC [1 ]
Wynalda, MA [1 ]
机构
[1] Pharm Corp, Kalamazoo, MI 49001 USA
关键词
D O I
10.1021/jm020248u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new and promising group of antibacterial agents, collectively known as the oxazolidinones and exemplified by linezolid (PNU-100766, marketed as Zyvox), have recently emerged as important new therapeutic agents for the treatment of infections caused by Gram-positive bacteria. Because of their significance, extensive synthetic investigations into the structure-activity relationships of the oxazolidinones have been conducted at Pharmacia. One facet of this research effort has focused on the identification of bioisosteric replacements for the usual oxazolidinone A-ring. In this paper we describe studies leading to the identification of antibacterial agents incorporating a novel isoxazoline A-ring surrogate. In a gratifying result, the initial isoxazoline analogue prepared was found to exhibit in vitro antibacterial activity approaching that of the corresponding oxazolidinone progenitor. The synthesis and antibacterial activity profile of a preliminary series of isoxazoline analogues incorporating either a C-C or N-C linkage between their B- and C-rings will be presented. Many of the analogues exhibited interesting levels of antibacterial activity. The piperazine derivative 54 displayed especially promising in vitro activity and in vivo efficacy comparable to the activity and efficacy of linezolid.
引用
收藏
页码:284 / 302
页数:19
相关论文
共 44 条
[1]   Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children [J].
Abi-Hanna, P ;
Frank, AL ;
Quinn, JP ;
Kelkar, S ;
Schreckenberger, PC ;
Hayden, MK ;
Marcinak, JF .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :630-631
[2]   THE PREPARATION OF OPTICALLY-ACTIVE DELTA-2-ISOXAZOLINES VIA ADDITION OF NITRILE OXIDES TO CHIRAL ACRYLOYL ESTERS BEARING CYCLITOLS AS AUXILIARIES [J].
AKIYAMA, T ;
OKADA, K ;
OZAKI, S .
TETRAHEDRON LETTERS, 1992, 33 (39) :5763-5766
[4]   Synthesis and antibacterial activity of new tropone-substituted phenyloxazolidinone antibacterial agents .1. Identification of leads and importance of the tropone substitution pattern. [J].
Barbachyn, MR ;
Toops, DS ;
Ulanowicz, DA ;
Grega, KC ;
Brickner, SJ ;
Ford, CW ;
Zurenko, GE ;
Hamel, JC ;
Schaadt, RD ;
Stapert, D ;
Yagi, BH ;
Buysse, JM ;
Demyan, WF ;
Kilburn, JO ;
Glickman, SE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (09) :1003-1008
[5]   Synthesis and antibacterial activity of new tropone-substituted phenyloxazolidinone antibacterial agents .2. Modification of the phenyl ring - The potentiating effect of fluorine substitution on in vivo activity. [J].
Barbachyn, MR ;
Toops, DS ;
Grega, KC ;
Hendges, SK ;
Ford, CW ;
Zurenko, GE ;
Hamel, JC ;
Schaadt, RD ;
Stapert, D ;
Yagi, BH ;
Buysse, JM ;
Demyan, WF ;
Kilburn, JO ;
Glickman, SE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (09) :1009-1014
[6]  
BARBACHYN MR, 1998, RESOLVING ANTIBIOTIC, pCH12
[7]  
Borthwick AD, 1996, MED CHEM RES, V6, P22
[8]  
CARAMELLA P, 1984, 1 3 DIPOLAR CYCLOADD, V1, pCH3
[9]  
Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V48, P1165
[10]  
CLEEK MR, 1999, 36 INT C ANT AG CHEM